We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $14.1B
1-Year Est. Return 30.11%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+30.11%
3 Year Est. Return
+110.39%
5 Year Est. Return
+152.15%
10 Year Est. Return
+370.53%
AUM
$14.1B
AUM Growth
+$741M
Cap. Flow
+$1.58B
Cap. Flow %
11.22%
Top 10 Hldgs %
38.76%
Holding
1,735
New
165
Increased
1,464
Reduced
57
Closed
49

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$110M
2
AAPL icon
Apple
AAPL
+$89M
3
MSFT icon
Microsoft
MSFT
+$81.1M
4
AMZN icon
Amazon
AMZN
+$54.3M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$45.4M

Top Sells

Rank Stock Value
1
PFG icon
Principal Financial Group
PFG
+$4.8M
2
KEY icon
KeyCorp
KEY
+$4.08M
3
SOLS
Solstice Advanced Materials
SOLS
+$3.06M
4
VLO icon
Valero Energy
VLO
+$2.61M
5
MNST icon
Monster Beverage
MNST
+$2.4M

Sector Composition

Rank Sector Weight
1 Technology 35.95%
2 Financials 11.04%
3 Consumer Discretionary 10.63%
4 Communication Services 10.59%
5 Healthcare 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRI icon
1401
Centuri Holdings
CTRI
$2.83B
$235K ﹤0.01%
+8,034
New +$234K
ABM icon
1402
ABM Industries
ABM
$2.75B
$234K ﹤0.01%
6,067
+890
+17% +$38.5K
PRK icon
1403
Park National Corp
PRK
$3.41B
$233K ﹤0.01%
+1,423
New +$233K
RHI icon
1404
Robert Half
RHI
$4.21B
$232K ﹤0.01%
+9,142
New +$242K
CLMT icon
1405
Calumet Specialty Products
CLMT
$3.85B
$232K ﹤0.01%
+6,462
New +$167K
TVTX icon
1406
Travere Therapeutics
TVTX
$5.26B
$232K ﹤0.01%
7,807
-252
-3% -$7.53K
SHOO icon
1407
Steven Madden
SHOO
$3.15B
$231K ﹤0.01%
6,800
+1,128
+20% +$43.7K
ADPT icon
1408
Adaptive Biotechnologies
ADPT
$3.61B
$230K ﹤0.01%
16,572
+1,753
+12% +$27.9K
DHT icon
1409
DHT Holdings
DHT
$2.97B
$230K ﹤0.01%
12,585
+2,065
+20% +$32.9K
FRME icon
1410
First Merchants
FRME
$2.77B
$229K ﹤0.01%
+5,925
New +$231K
WAFD icon
1411
WaFd
WAFD
$2.74B
$229K ﹤0.01%
+7,308
New +$235K
DX
1412
Dynex Capital
DX
$2.8B
$229K ﹤0.01%
17,971
+6,458
+56% +$88.8K
VERA icon
1413
Vera Therapeutics
VERA
$2.67B
$229K ﹤0.01%
5,689
+1,330
+31% +$57.3K
ARCB icon
1414
ArcBest
ARCB
$3.58B
$229K ﹤0.01%
+2,325
New +$220K
LQDA icon
1415
Liquidia Corp
LQDA
$7.19B
$228K ﹤0.01%
+6,046
New +$224K
PPTA
1416
Perpetua Resources
PPTA
$2.33B
$228K ﹤0.01%
+8,100
New +$245K
SPNT icon
1417
SiriusPoint
SPNT
$2.88B
$227K ﹤0.01%
+10,543
New +$217K
JOE icon
1418
St. Joe Company
JOE
$3.48B
$227K ﹤0.01%
+3,612
New +$242K
PRVA icon
1419
Privia Health
PRVA
$3.32B
$227K ﹤0.01%
11,017
+1,837
+20% +$41.4K
PRDO icon
1420
Perdoceo Education
PRDO
$1.91B
$226K ﹤0.01%
+6,071
New +$201K
FHB icon
1421
First Hawaiian
FHB
$3.54B
$226K ﹤0.01%
+9,167
New +$236K
RXO icon
1422
RXO
RXO
$4.83B
$225K ﹤0.01%
15,362
+2,503
+19% +$36.7K
ADNT icon
1423
Adient
ADNT
$1.56B
$224K ﹤0.01%
11,098
+838
+8% +$18.6K
TRMK icon
1424
Trustmark
TRMK
$2.73B
$223K ﹤0.01%
+5,296
New +$223K
BANC icon
1425
Banc of California
BANC
$3.37B
$223K ﹤0.01%
12,687
+2,588
+26% +$49.4K
55 56
57
58 59

Similar funds

CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $14.1B AUM 25.71% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Xponance's Q1 2026 Portfolio in Review

As of Q1 2026, Xponance held 1,735 positions worth $14.1B, up 5.6% from $13.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance deployed $1.58B of net new capital in Q1 2026, opening 165 new positions and adding to 1,464 existing holdings. Its largest new stake was Medline Inc: 22,732 shares worth $1.01M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Principal Financial Group, an estimated $4.8M trimmed.

  • Xponance's largest Q1 2026 buy was Medline Inc: 22,732 shares worth $1.01M.
  • Xponance added most to NVIDIA in Q1 2026, an estimated $110M increase.
  • Xponance's biggest Q1 2026 reduction was Principal Financial Group, cutting an estimated $4.8M.
  • Xponance fully exited Confluent in Q1 2026, selling an estimated $1.34M.
  • Xponance's ten largest holdings make up 39% of its $14.1B portfolio in Q1 2026.
  • Xponance opened 165 new positions and closed 49 in Q1 2026.
  • Xponance's portfolio value rose 5.6% quarter-over-quarter to $14.1B.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.